Cargando…

A case control study examining the feasibility of using eye tracking perimetry to differentiate patients with glaucoma from healthy controls

To explore the feasibility of using Saccadic Vector Optokinetic Perimetry (SVOP) to differentiate glaucomatous and healthy eyes. A prospective case–control study was performed using a convenience sample recruited from a single university glaucoma clinic and a group of healthy controls. SVOP and stan...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatham, Andrew J., Murray, Ian C., McTrusty, Alice D., Cameron, Lorraine A., Perperidis, Antonios, Brash, Harry M., Fleck, Brian W., Minns, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804427/
https://www.ncbi.nlm.nih.gov/pubmed/33436922
http://dx.doi.org/10.1038/s41598-020-80401-2
_version_ 1783636161680375808
author Tatham, Andrew J.
Murray, Ian C.
McTrusty, Alice D.
Cameron, Lorraine A.
Perperidis, Antonios
Brash, Harry M.
Fleck, Brian W.
Minns, Robert A.
author_facet Tatham, Andrew J.
Murray, Ian C.
McTrusty, Alice D.
Cameron, Lorraine A.
Perperidis, Antonios
Brash, Harry M.
Fleck, Brian W.
Minns, Robert A.
author_sort Tatham, Andrew J.
collection PubMed
description To explore the feasibility of using Saccadic Vector Optokinetic Perimetry (SVOP) to differentiate glaucomatous and healthy eyes. A prospective case–control study was performed using a convenience sample recruited from a single university glaucoma clinic and a group of healthy controls. SVOP and standard automated perimetry (SAP) was performed with testing order randomised. The reference standard was a diagnosis of glaucoma based a comprehensive ophthalmic examination and abnormality on standard automated perimetry (SAP). The index test was SVOP. 31 patients with glaucoma and 24 healthy subjects were included. Mean SAP mean deviation (MD) in those with glaucoma was − 8.7 ± 7.4 dB, with mean SAP and SVOP sensitivities of 23.3 ± 0.9 dB and 22.1 ± 4.3 dB respectively. Participants with glaucoma were significantly older. On average, SAP sensitivity was 1.2 ± 1.4 dB higher than SVOP (95% limits of agreement = − 1.6 to 4.0 dB). SVOP sensitivity had good ability to differentiate healthy and glaucomatous eyes with a 95% CI for area under the curve (AUC) of 0.84 to 0.96, similar to the performance of SAP sensitivity (95% CI 0.86 to 0.97, P = 0.60). For 80% specificity, SVOP had a 95% CI sensitivity of 75.7% to 94.8% compared to 77.8% to 96.0% for SAP. SVOP took considerably longer to perform (514 ± 54 s compared to 267 ± 76 s for SAP). Eye tracking perimetry may be useful for detection of glaucoma but further studies are needed to evaluate SVOP within its intended sphere of use, using an appropriate design and independent reference standard.
format Online
Article
Text
id pubmed-7804427
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78044272021-01-13 A case control study examining the feasibility of using eye tracking perimetry to differentiate patients with glaucoma from healthy controls Tatham, Andrew J. Murray, Ian C. McTrusty, Alice D. Cameron, Lorraine A. Perperidis, Antonios Brash, Harry M. Fleck, Brian W. Minns, Robert A. Sci Rep Article To explore the feasibility of using Saccadic Vector Optokinetic Perimetry (SVOP) to differentiate glaucomatous and healthy eyes. A prospective case–control study was performed using a convenience sample recruited from a single university glaucoma clinic and a group of healthy controls. SVOP and standard automated perimetry (SAP) was performed with testing order randomised. The reference standard was a diagnosis of glaucoma based a comprehensive ophthalmic examination and abnormality on standard automated perimetry (SAP). The index test was SVOP. 31 patients with glaucoma and 24 healthy subjects were included. Mean SAP mean deviation (MD) in those with glaucoma was − 8.7 ± 7.4 dB, with mean SAP and SVOP sensitivities of 23.3 ± 0.9 dB and 22.1 ± 4.3 dB respectively. Participants with glaucoma were significantly older. On average, SAP sensitivity was 1.2 ± 1.4 dB higher than SVOP (95% limits of agreement = − 1.6 to 4.0 dB). SVOP sensitivity had good ability to differentiate healthy and glaucomatous eyes with a 95% CI for area under the curve (AUC) of 0.84 to 0.96, similar to the performance of SAP sensitivity (95% CI 0.86 to 0.97, P = 0.60). For 80% specificity, SVOP had a 95% CI sensitivity of 75.7% to 94.8% compared to 77.8% to 96.0% for SAP. SVOP took considerably longer to perform (514 ± 54 s compared to 267 ± 76 s for SAP). Eye tracking perimetry may be useful for detection of glaucoma but further studies are needed to evaluate SVOP within its intended sphere of use, using an appropriate design and independent reference standard. Nature Publishing Group UK 2021-01-12 /pmc/articles/PMC7804427/ /pubmed/33436922 http://dx.doi.org/10.1038/s41598-020-80401-2 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Tatham, Andrew J.
Murray, Ian C.
McTrusty, Alice D.
Cameron, Lorraine A.
Perperidis, Antonios
Brash, Harry M.
Fleck, Brian W.
Minns, Robert A.
A case control study examining the feasibility of using eye tracking perimetry to differentiate patients with glaucoma from healthy controls
title A case control study examining the feasibility of using eye tracking perimetry to differentiate patients with glaucoma from healthy controls
title_full A case control study examining the feasibility of using eye tracking perimetry to differentiate patients with glaucoma from healthy controls
title_fullStr A case control study examining the feasibility of using eye tracking perimetry to differentiate patients with glaucoma from healthy controls
title_full_unstemmed A case control study examining the feasibility of using eye tracking perimetry to differentiate patients with glaucoma from healthy controls
title_short A case control study examining the feasibility of using eye tracking perimetry to differentiate patients with glaucoma from healthy controls
title_sort case control study examining the feasibility of using eye tracking perimetry to differentiate patients with glaucoma from healthy controls
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804427/
https://www.ncbi.nlm.nih.gov/pubmed/33436922
http://dx.doi.org/10.1038/s41598-020-80401-2
work_keys_str_mv AT tathamandrewj acasecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols
AT murrayianc acasecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols
AT mctrustyaliced acasecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols
AT cameronlorrainea acasecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols
AT perperidisantonios acasecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols
AT brashharrym acasecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols
AT fleckbrianw acasecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols
AT minnsroberta acasecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols
AT tathamandrewj casecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols
AT murrayianc casecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols
AT mctrustyaliced casecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols
AT cameronlorrainea casecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols
AT perperidisantonios casecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols
AT brashharrym casecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols
AT fleckbrianw casecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols
AT minnsroberta casecontrolstudyexaminingthefeasibilityofusingeyetrackingperimetrytodifferentiatepatientswithglaucomafromhealthycontrols